Exactech Announces Shareholding Acquisition of JointMedica, Signaling Return of Hip Resurfacing
Retrieved on:
Monday, January 24, 2022
Biotechnology, Health, Surgery, Medical Devices, Patient, Active, Surgeon, Smith & Nephew, LinkedIn, Hip, Smith, Percussion section, CEO, Â, Instagram, Metal-insulator-metal, History, View, TM, FRCS, YouTube, BHR, Twitter, Trademark, DRS, Hospital, Senior, Partnership, Physician, Acquisition, Medical device, MD, Pacific Ocean, McMinn, JointMedica, Exactech, JOINTMEDICA, EXACTECH
The companies will collaborate to deliver the next generation of hip resurfacing to the global market with JointMedicas primary product, the Polymotion hip implant.
Key Points:
- The companies will collaborate to deliver the next generation of hip resurfacing to the global market with JointMedicas primary product, the Polymotion hip implant.
- Derek McMinn MD, FRCS, and Ronan Treacy, MD, FRCS, the original designers of the well-documented Birmingham Hip Resurfacing device (BHR), have partnered to develop another major advancement in hip replacement.
- This partnership will bring to market JointMedicas advanced polyethene hip resurfacing, using Exactechs global outreach, said McMinn.
- The Polymotion hip offers the biomechanical benefits of hip resurfacing but eliminates metal-on-metal articulating surfaces.